A previous study reported that CompC reduced the anti-invasive effect induced by fenofibrate, a peroxisome proliferator-activated receptor alpha (PPARα) agonist and a lipid-lowering agent, in human oral cancer CAL 27 cells in an AMPK-dependent manner [24]. The gene discussed is PPARA; the disease is lip and oral cavity carcinoma.